株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

ユーバイオティクスの世界市場の予測 〜2022年:タイプ (プロバイオティクス・プレバイオティクス・有機酸・精油)・家畜・形態・機能別

Eubiotics Market by Type (Probiotics, Prebiotics, Organic Acids, Essential Oils), Livestock (Swine, Poultry, Ruminant, Aquaculture), Form (Dry and Liquid), Function (Nutrition & Gut Health, Yield, Immunity, Production) - Global Forecast to 2022

発行 MarketsandMarkets 商品コード 298905
出版日 ページ情報 英文 184 Pages
即納可能
価格
本日の銀行送金レート: 1USD=116.15円で換算しております。
Back to Top
ユーバイオティクスの世界市場の予測 〜2022年:タイプ (プロバイオティクス・プレバイオティクス・有機酸・精油)・家畜・形態・機能別 Eubiotics Market by Type (Probiotics, Prebiotics, Organic Acids, Essential Oils), Livestock (Swine, Poultry, Ruminant, Aquaculture), Form (Dry and Liquid), Function (Nutrition & Gut Health, Yield, Immunity, Production) - Global Forecast to 2022
出版日: 2016年12月07日 ページ情報: 英文 184 Pages
概要

世界のユーバイオティクスの市場は2016年から7.51%のCAGR (年間複合成長率) で推移し、2022年には74億7000万米ドルの規模に成長すると予測されています。

当レポートでは、世界のユーバイオティクスの市場を調査し、市場および製品の概要、産業構造とバリューチェーン、市場への各種影響因子および市場機会の分析、製品タイプ・家畜区分・形態・機能・地域/主要国別の動向と市場規模の推移と予測、競合環境と企業ランキング、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 魅力的な市場機会
  • 主要国市場
  • ライフサイクル分析:地域別
  • タイプ別市場
  • 市場の実績・予測:先進国市場 vs 新興国市場
  • 市場実績:形態・地域別

第5章 ユーバイオティクスの世界市場:概要

  • イントロダクション
    • ユーバイオティクスの各種タイプ
      • プロバイオティクス
      • プレバイオティクス
      • 有機酸
      • 精油
  • マクロ指標
  • 市場区分
  • 市場力学
    • 成長推進因子
    • 成長阻害因子
    • 市場機会
    • 課題
  • 法規制
    • 飼料添加物としての抗生物質
    • 抗生物質の禁止
      • 欧州
      • 韓国
      • 米国

第6章 ユーバイオティクスの世界市場:産業動向

  • イントロダクション
  • バリューチェーン分析
  • サプライチェーン分析
  • ポーターのファイブフォース分析
  • 特許分析

第7章 ユーバイオティクスの世界市場:タイプ別

  • イントロダクション
  • プロバイオティクス
    • ラクトバチルス
    • ビフィズス菌
  • プレバイオティクス
    • イヌリン
    • フルクトオリゴ糖 (FOS)
    • ガラクトオリゴ糖 (GOS)
    • マンナンオリゴ糖 (MOS)
  • 有機酸
    • ギ酸
    • 乳酸
    • フマル酸
    • プロピオン酸
    • 酢酸
  • 精油

第8章 ユーバイオティクスの世界市場:家畜別

  • イントロダクション
  • 反芻動物
  • 水棲動物
  • その他

第9章 ユーバイオティクスの世界市場:形態別

  • イントロダクション
  • ドライ
  • 液体

第10章 ユーバイオティクスの世界市場:機能別

  • イントロダクション
  • 栄養・腸の健康
  • 収量
  • 免疫
  • 生産性

第11章 ユーバイオティクスの世界市場:地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ロシア
    • スイス
    • その他
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他
  • その他
    • ブラジル
    • アルゼンチン
    • 南アフリカ
    • その他

第12章 競合環境

  • 概要
  • 企業ランキング
  • 競合状況・動向
  • 拡張・投資:主要戦略
    • 拡張・投資
    • M&A
    • 新製品の投入
    • 合意・提携・強力・ジョイントベンチャー

第13章 企業プロファイル

  • イントロダクション
  • CARGILL
  • BASF SE
  • E.I. DUPONT DE NEMOURS AND COMPANY
  • KONINKLIJKE DSM N.V.
  • CHR. HANSEN HOLDING A/S
  • NOVOZYMES
  • CALPIS CO., LTD.
  • LESAFFRE GROUP
  • KEMIN INDUSTRIES, INC.
  • LALLEMAND, INC.
  • ADDCON
  • BEHN MEYER GROUP
  • NOVUS INTERNATIONAL, INC.
  • ADVANCED BIO NUTRITION CORP
  • BENEO GROUP
    • 企業概要
    • 財務動向
    • 製品・サービス
    • 戦略
    • 近年の発展動向、など

第14章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: AGI 2342

Global eubiotics market projected to grow at a CAGR of 7.51%

The global eubiotics market is projected to reach a value of USD 7.47 billion by 2022, growing at a CAGR of 7.51% from 2016. The demand for eubiotics in animal feed is projected to grow during the forecast period, owing to the rapidly increasing global demand for quality animal products. The eubiotics market is influenced by the growth of the awareness among consumers with respect to preventive healthcare and nutrition. The biotechnology industry is now creating an opportunity for growth in the eubiotics sector. Factors such as low shelf life of eubiotics and high cost of eubiotics leading to the rise in cost of production are restraining the growth of the market.

Probiotics segment accounted for the largest market share in 2015 among the types of eubiotics

On the basis of type, eubiotics have been segmented into probiotics, prebiotics, organic acids, and essential oils. Among these, the probiotics segment accounted for the largest market share in 2015, followed by the organic acids and prebiotics segments, respectively. Probiotics are largely used for poultry, for healthy growth.

Poultry segment led the market with the largest share in 2015

On the basis of livestock, the eubiotics market has been segmented into swine, ruminants, poultry, aquatic animals, and others, which include horses, sheep, and birds. The market was led by poultry followed by swine. Eubiotics are mixtures of carbohydrates and proteins, which help in strengthening the immune system and also act as growth promoters. Eubiotics help in adding nutritional value to animal feed.

European region dominated the market with the largest share

Europe formed the largest market for eubiotics in 2015, whereas Asia-Pacific accounted for the second-largest market share in 2015. The application of eubiotics in animal feed is estimated to increase at a faster pace in the European and Asia-Pacific regions due to the rise in demand from consumers. The farming techniques used in the region require healthy and strong farm animals, and eubiotics helps in balancing digestive systems and enhancing immunity systems of the livestock. The changing dietary pattern has led to increased meat consumption among the people of Asia-Pacific, which has led to the industrialization of meat production in the region. The demand for healthy livestock is fueling the demand for eubiotics-based animal feed.

Breakdown of profiles of primary participants is as follows:

  • By Company Type: Tier 1 - 30 %, Tier 2 - 45%, and Tier 3 - 25%
  • By Designation: Directors - 22%, C level - 28%, and Manager level - 50%
  • By Region: North America - 35%, Europe - 23%, Asia-Pacific - 32%, and RoW - 10%

The key players identified in the global eubiotics market include Cargill (U.S.), BASF SE (Germany), E. I. du Pont de Nemours and Company (U.S.), Koninklijke DSM N. V. (Netherlands), Chr. Hansen A/S (Denmark), Novozymes (Denmark), Calpis Co., Ltd. (Japan), Lesaffre Group (France), Kemin Industries, Inc. (U.S.), Lallemand Inc. (Canada), ADDCON (Germany), Behn Meyer (Malaysia), Novus International Inc. (U.S.), and Advanced BioNutrition Corporation (U.S.).

Research Coverage:

  • This study estimates the global market of eubiotics, in terms of dollar value, till 2022, segmented on the basis of type, livestock, function, and form.
  • It offers a detailed qualitative and quantitative analysis of this market with reference to the competitive landscape, and preferred development strategies such as expansions and investments and to gain a larger share in the market.
  • It provides a comprehensive review of major market drivers, restraints, opportunities, challenges, winning imperatives, and key issues of the market.
  • It covers various important aspects of the market. These include analysis of the value chain, Porter's Five Forces model, competitive landscape, market dynamics, market estimates, in terms of value, and future trends in the eubiotics market.

Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analyses-industry analysis (industry trends), market share analysis of top players, supply chain analysis, and company profiles, which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth segments of the eubiotics market; high-growth regions; and market drivers, restraints, and opportunities.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on eubiotics offered by the top players in the global eubiotics market
  • Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new product launches in the eubiotics market
  • Market Development: Comprehensive information about lucrative emerging markets-the report analyzes the markets for eubiotics across various regions
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global eubiotics market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the global eubiotics market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. STUDY SCOPE
    • 1.3.1. MARKET COVERED
    • 1.3.2. PERIODIZATION CONSIDERED
  • 1.4. CURRENCY CONSIDERED
  • 1.5. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. INTRODUCTION
  • 2.2. RESEARCH DATA
    • 2.2.1. SECONDARY DATA
      • 2.2.1.1. Key data from secondary sources
    • 2.2.2. PRIMARY DATA
      • 2.2.2.1. Key data from primary sources
      • 2.2.2.2. Key industry insights
      • 2.2.2.3. Breakdown of primary interviews
  • 2.3. MARKET SIZE ESTIMATION
    • 2.3.1. BOTTOM-UP APPROACH
    • 2.3.2. TOP-DOWN APPROACH
  • 2.4. MARKET BREAKDOWN & DATA TRIANGULATION
  • 2.5. RESEARCH ASSUMPTIONS & LIMITATIONS
    • 2.5.1. ASSUMPTIONS
    • 2.5.2. LIMITATIONS

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. ATTRACTIVE OPPORTUNITIES IN THE EUBIOTICS MARKET
  • 4.2. EUBIOTICS MARKETS: KEY COUNTRIES
  • 4.3. LIFE CYCLE ANALYSIS: EUBIOTICS MARKET, BY REGION
  • 4.4. EUBIOTICS MARKET, BY TYPE
  • 4.5. DEVELOPED VS. EMERGING EUBIOTICS MARKETS, 2016 VS. 2022
  • 4.6. EUBIOTICS MARKET, BY FORM & REGION, 2015

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
    • 5.1.1. TYPES OF EUBIOTICS
      • 5.1.1.1. Probiotics
      • 5.1.1.2. Prebiotics
      • 5.1.1.3. Essential oils
      • 5.1.1.4. Organic acids
  • 5.2. MACROINDICATORS
    • 5.2.1. INTRODUCTION
      • 5.2.1.1. Growing population and rising demand for diversified food
      • 5.2.1.2. Increase in meat production/consumption
      • 5.2.1.3. Parent Market Analysis: Animal Feed Industry
  • 5.3. MARKET SEGMENTATION
    • 5.3.1. BY TYPE
    • 5.3.2. BY FUNCTION
    • 5.3.3. BY FORM
    • 5.3.4. BY LIVESTOCK
  • 5.4. MARKET DYNAMICS
    • 5.4.1. DRIVERS
      • 5.4.1.1. Increasing awareness about feed quality and safety
      • 5.4.1.2. Replacing antibiotic growth promoters (AGPs) with eubiotics
      • 5.4.1.3. Rising demand for manufactured animal feed
      • 5.4.1.4. Growth in demand for animal protein
    • 5.4.2. RESTRAINTS
      • 5.4.2.1. Trade complexities due to regulatory structure
      • 5.4.2.2. Food production chain increasingly complex
    • 5.4.3. OPPORTUNITIES
      • 5.4.3.1. Increasing investments and opportunities in Animal Nutrition
      • 5.4.3.2. Heightened consumer awareness
      • 5.4.3.3. Rise in the pet industry spending
    • 5.4.4. CHALLENGES
      • 5.4.4.1. Rise in raw material prices
      • 5.4.4.2. Increasing disease outbreaks in livestock
  • 5.5. REGULATORY FRAMEWORK
    • 5.5.1. ANTIBIOTICS AS FEED ADDITIVES
    • 5.5.2. BAN ON ANTIBIOTICS
      • 5.5.2.1. Europe
      • 5.5.2.2. South Korea
      • 5.5.2.3. U.S.

6. INDUSTRY TRENDS

  • 6.1. INTRODUCTION
  • 6.2. VALUE CHAIN ANALYSIS
  • 6.3. SUPPLY CHAIN ANALYSIS
    • 6.3.1. PROMINENT COMPANIES
    • 6.3.2. SMALL & MEDIUM ENTERPRISES
    • 6.3.3. END USERS
  • 6.4. PORTER'S FIVE FORCES ANALYSIS
    • 6.4.1. INTENSITY OF COMPETITIVE RIVALRY
    • 6.4.2. BARGAINING POWER OF SUPPLIERS
    • 6.4.3. BARGAINING POWER OF BUYERS
    • 6.4.4. THREAT OF NEW ENTRANTS
    • 6.4.5. THREAT OF SUBSTITUTES
  • 6.5. PATENT ANALYSIS

7. EUBIOTICS MARKET, BY TYPE

  • 7.1. INTRODUCTION
  • 7.2. PROBIOTICS
    • 7.2.1. LACTOBACILLI
      • 7.2.1.1. Research on lactobacilli
    • 7.2.2. BIFIDOBACTERIA
      • 7.2.2.1. Research on bifidobacteria
    • 7.2.3. STREPTOCOCCUS THERMOPHILUS
    • 7.2.4. OTHER BACTERIA
  • 7.3. PREBIOTICS
    • 7.3.1. INULIN
    • 7.3.2. FRUCTO-OLIGOSACCHARIDES (FOS)
    • 7.3.3. GALACTO-OLIGOSACCHARIDES (GOS)
    • 7.3.4. MANNAN-OLIGOSACCHARIDE (MOS)
  • 7.4. ORGANIC ACIDS
    • 7.4.1. FORMIC ACID
    • 7.4.2. LACTIC ACID
    • 7.4.3. FUMARIC ACID
    • 7.4.4. PROPIONIC ACID
    • 7.4.5. ACETIC ACID
  • 7.5. ESSENTIAL OILS

8. EUBIOTICS MARKET, BY LIVESTOCK

  • 8.1. INTRODUCTION
    • 8.1.1. KEY FEATURES
      • 8.1.1.1. Modulation of microflora
      • 8.1.1.2. Stimulation of immune response
      • 8.1.1.3. Metabolite excretion
  • 8.2. SWINE
    • 8.2.1. KEY FEATURES
      • 8.2.1.1. Stimulate and Neutralize
      • 8.2.1.2. Protection against infection
  • 8.3. POULTRY
    • 8.3.1. KEY FEATURES
      • 8.3.1.1. Growth and improved feed conversion rate
  • 8.4. RUMINANTS
  • 8.5. AQUATIC ANIMALS
  • 8.6. OTHER LIVESTOCK

9. EUBIOTICS MARKET, BY FORM

  • 9.1. INTRODUCTION
    • 9.1.1. DRY FORM
    • 9.1.2. LIQUID FORM

10. EUBIOTICS MARKET, BY FUNCTION

  • 10.1. INTRODUCTION
  • 10.2. NUTRITION & GUT HEALTH
  • 10.3. YIELD
  • 10.4. IMMUNITY
  • 10.5. PRODUCTIVITY

11. EUBIOTICS MARKET, BY REGION

  • 11.2. INTRODUCTION
  • 11.3. NORTH AMERICA
    • 11.3.1. U.S.
    • 11.3.2. CANADA
    • 11.3.3. MEXICO
  • 11.4. EUROPE
    • 11.4.1. U.K.
    • 11.4.2. GERMANY
    • 11.4.3. FRANCE
    • 11.4.4. ITALY
    • 11.4.5. SPAIN
    • 11.4.6. RUSSIA
    • 11.4.7. SWITZERLAND
    • 11.4.8. REST OF EUROPE
  • 11.5. ASIA-PACIFIC
    • 11.5.1. CHINA
    • 11.5.2. INDIA
    • 11.5.3. JAPAN
    • 11.5.4. AUSTRALIA
    • 11.5.5. REST OF ASIA-PACIFIC
  • 11.6. REST OF THE WORLD (ROW)
    • 11.6.1. BRAZIL
    • 11.6.2. ARGENTINA
    • 11.6.3. SOUTH AFRICA
    • 11.6.4. OTHERS IN ROW

12. COMPETITIVE LANDSCAPE

  • 12.1. OVERVIEW
  • 12.2. EUBIOTICS MARKET: COMPANY RANKING
  • 12.3. COMPETITIVE SITUATION & TRENDS
  • 12.4. EXPANSIONS & INVESTMENTS: THE KEY STRATEGY, 2010-2016
    • 12.4.1. EXPANSIONS & INVESTMENTS
    • 12.4.2. MERGERS & ACQUISITIONS
    • 12.4.3. NEW PRODUCT LAUNCHES
    • 12.4.4. AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, AND JOINT VENTURES

13. COMPANY PROFILES (Company at a Glance, Recent Financials, Products & Services, Strategies & Insights, & Recent Developments)*

  • 13.1. CARGILL
  • 13.2. BASF SE
  • 13.3. E.I. DUPONT DE NEMOURS AND COMPANY
  • 13.4. KONINKLIJKE DSM N.V.
  • 13.5. CHR. HANSEN HOLDING A/S
  • 13.6. NOVOZYMES
  • 13.7. CALPIS CO., LTD.
  • 13.8. LESAFFRE GROUP
  • 13.9. KEMIN INDUSTRIES, INC.
  • 13.10. LALLEMAND, INC.
  • 13.11. ADDCON
  • 13.12. BEHN MEYER GROUP
  • 13.13. NOVUS INTERNATIONAL, INC.
  • 13.14. ADVANCED BIO NUTRITION CORP
  • 13.15. BENEO GROUP

*Details on company at a glance, recent financials, products & services, strategies & insights, & recent developments might not be captured in case of unlisted companies.

14. APPENDIX

  • 14.1. INSIGHTS OF INDUSTRY EXPERTS
  • 14.2. DISCUSSION GUIDE
    • 14.2.1. EXPANSIONS & INVESTMENTS
    • 14.2.2. MERGERS & ACQUISITIONS
    • 14.2.3. NEW PRODUCT LAUNCHES
    • 14.2.4. AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, AND JOINT VENTURES
  • 14.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.4. AVAILABLE CUSTOMIZATIONS
  • 14.5. RELATED REPORTS
  • 14.6. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: PER CAPITA CONSUMPTION OF MEAT THROUGH 2030
  • TABLE 2: TYPICAL BROILER PERFORMANCE WITH EUBIOTIC NUTRITION IN THE NETHERLANDS, 2015
  • TABLE 3: PROTEIN SUPPLY PER CAPITA FOR KEY COUNTRIES, 2006-2009 (GRAMS/DAY)
  • TABLE 4: LIST OF MAJOR PATENTS IN PROBIOTICS IN ANIMAL FEED, 2012-2016
  • TABLE 5: LIST OF MAJOR PATENTS IN PREBIOTICS IN ANIMAL FEED, 2012-2016
  • TABLE 6: LIST OF MAJOR PATENTS IN ESSENTIAL OILS IN ANIMAL FEED, 2012-2016
  • TABLE 7: EUBIOTICS MARKET SIZE, BY TYPE, 2014-2022 (USD MILLION)
  • TABLE 8: EUBIOTICS MARKET SIZE, BY TYPE, 2014-2022 (KT)
  • TABLE 9: PROBIOTICS MARKET SIZE, BY REGION, 2014-2022 (USD MILLION)
  • TABLE 10: PREBIOTICS MARKET SIZE, BY REGION, 2014-2022 (USD MILLION)
  • TABLE 11: ORGANIC ACIDS MARKET SIZE, BY REGION, 2014-2022 (USD MILLION)
  • TABLE 12: ESSENTIAL OILS MARKET SIZE, BY REGION, 2014-2022 (USD MILLION)
  • TABLE 13: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2014-2022 (USD MILLION)
  • TABLE 14: SWINE: EUBIOTICS MARKET SIZE, BY REGION, 2014-2022 (USD MILLION)
  • TABLE 15: POULTRY: EUBIOTICS MARKET SIZE, BY REGION, 2014-2022 (USD MILLION)
  • TABLE 16: RUMINANTS: EUBIOTICS MARKET SIZE, BY REGION, 2014-2022 (USD MILLION)
  • TABLE 17: AQUATIC ANIMALS: EUBIOTICS MARKET SIZE, BY REGION, 2014-2022 (USD MILLION)
  • TABLE 18: OTHER LIVESTOCK: EUBIOTICS MARKET SIZE, BY REGION, 2014-2022 (USD MILLION)
  • TABLE 19: EUBIOTICS MARKET SIZE, BY FORM, 2014-2022 (USD MILLION)
  • TABLE 20: DRY EUBIOTICS MARKET SIZE, BY REGION, 2014-2022 (USD MILLION)
  • TABLE 21: LIQUID EUBIOTICS MARKET SIZE, BY REGION, 2014-2022 (USD MILLION)
  • TABLE 22: EUBIOTICS MARKET SIZE, BY REGION, 2014-2022 (USD MILLION)
  • TABLE 23: NORTH AMERICA: EUBIOTICS MARKET SIZE, BY COUNTRY, 2014-2022 (USD MILLION)
  • TABLE 24: NORTH AMERICA: EUBIOTICS MARKET SIZE, BY TYPE, 2014-2022 (USD MILLION)
  • TABLE 25: NORTH AMERICA: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2014-2022 (USD MILLION)
  • TABLE 26: NORTH AMERICA: EUBIOTICS MARKET SIZE, BY FORM, 2014-2022 (USD MILLION)
  • TABLE 27: U.S.: EUBIOTICS MARKET SIZE, BY TYPE, 2014-2022 (USD MILLION)
  • TABLE 28: U.S.: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2014-2022 (USD MILLION)
  • TABLE 29: CANADA: EUBIOTICS MARKET SIZE, BY TYPE, 2014-2022 (USD MILLION)
  • TABLE 30: CANADA: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2014-2022 (USD MILLION)
  • TABLE 31: MEXICO: EUBIOTICS MARKET SIZE, BY TYPE, 2014-2022 (USD MILLION)
  • TABLE 32: MEXICO: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2014-2022 (USD MILLION)
  • TABLE 33: EUROPE: EUBIOTICS MARKET SIZE, BY COUNTRY, 2014-2022 (USD MILLION)
  • TABLE 34: EUROPE: EUBIOTICS MARKET SIZE, BY TYPE, 2014-2022 (USD MILLION)
  • TABLE 35: EUROPE: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2014-2022 (USD MILLION)
  • TABLE 36: EUROPE: EUBIOTICS MARKET SIZE, BY FORM, 2014-2022 (USD MILLION)
  • TABLE 37: U.K.: EUBIOTICS MARKET SIZE, BY TYPE, 2014-2022 (USD MILLION)
  • TABLE 38: U.K.: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2014-2022 (USD MILLION)
  • TABLE 39: GERMANY: EUBIOTICS MARKET SIZE, BY TYPE, 2014-2022 (USD MILLION)
  • TABLE 40: GERMANY: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2014-2022 (USD MILLION)
  • TABLE 41: FRANCE: EUBIOTICS MARKET SIZE, BY TYPE, 2014-2022 (USD MILLION)
  • TABLE 42: FRANCE: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2014-2022 (USD MILLION)
  • TABLE 43: ITALY: EUBIOTICS MARKET SIZE, BY TYPE, 2014-2022 (USD MILLION)
  • TABLE 44: ITALY: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2014-2022 (USD MILLION)
  • TABLE 45: SPAIN: EUBIOTICS MARKET SIZE, BY TYPE, 2014-2022 (USD MILLION)
  • TABLE 46: SPAIN: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2014-2022 (USD MILLION)
  • TABLE 47: RUSSIA: EUBIOTICS MARKET SIZE, BY TYPE, 2014-2022 (USD MILLION)
  • TABLE 48: RUSSIA: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2014-2022 (USD MILLION)
  • TABLE 49: SWITZERLAND: EUBIOTICS MARKET SIZE, BY TYPE, 2014-2022 (USD MILLION)
  • TABLE 50: SWITZERLAND: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2014-2022 (USD MILLION)
  • TABLE 51: REST OF EUROPE: EUBIOTICS MARKET SIZE, BY TYPE, 2014-2022 (USD MILLION)
  • TABLE 52: REST OF EUROPE: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2014-2022 (USD MILLION)
  • TABLE 53: ASIA-PACIFIC: EUBIOTICS MARKET SIZE, BY COUNTRY, 2014-2022 (USD MILLION)
  • TABLE 54: ASIA-PACIFIC: EUBIOTICS MARKET SIZE, BY TYPE, 2014-2022 (USD MILLION)
  • TABLE 55: ASIA-PACIFIC: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2014-2022 (USD MILLION)
  • TABLE 56: ASIA-PACIFIC: EUBIOTICS MARKET SIZE, BY FORM, 2014-2022 (USD MILLION)
  • TABLE 57: CHINA: EUBIOTICS MARKET SIZE, BY TYPE, 2014-2022 (USD MILLION)
  • TABLE 58: CHINA: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2014-2022 (USD MILLION)
  • TABLE 59: INDIA: EUBIOTICS MARKET SIZE, BY TYPE, 2014-2022 (USD MILLION)
  • TABLE 60: INDIA: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2014-2022 (USD MILLION)
  • TABLE 61: JAPAN: EUBIOTICS MARKET SIZE, BY TYPE, 2014-2022 (USD MILLION)
  • TABLE 62: JAPAN: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2014-2022 (USD MILLION)
  • TABLE 63: AUSTRALIA: EUBIOTICS MARKET SIZE, BY TYPE, 2014-2022 (USD MILLION)
  • TABLE 64: AUSTRALIA: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2014-2022 (USD MILLION)
  • TABLE 65: REST OF ASIA-PACIFIC: EUBIOTICS MARKET SIZE, BY TYPE, 2014-2022 (USD MILLION)
  • TABLE 66: REST OF ASIA-PACIFIC: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2014-2022 (USD MILLION)
  • TABLE 67: ROW: EUBIOTICS MARKET SIZE, BY COUNTRY, 2014-2022 (USD MILLION)
  • TABLE 68: ROW: EUBIOTICS MARKET SIZE, BY TYPE, 2014-2022 (USD MILLION)
  • TABLE 69: ROW: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2014-2022 (USD MILLION)
  • TABLE 70: ROW: EUBIOTICS MARKET SIZE, BY FORM, 2014-2022 (USD MILLION)
  • TABLE 71: BRAZIL: EUBIOTICS MARKET SIZE, BY TYPE, 2014-2022 (USD MILLION)
  • TABLE 72: BRAZIL: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2014-2022 (USD MILLION)
  • TABLE 73: ARGENTINA: EUBIOTICS MARKET SIZE, BY TYPE, 2014-2022 (USD MILLION)
  • TABLE 74: ARGENTINA: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2014-2022 (USD MILLION)
  • TABLE 75: SOUTH AFRICA: EUBIOTICS MARKET SIZE, BY TYPE, 2014-2022 (USD MILLION)
  • TABLE 76: SOUTH AFRICA: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2014-2022 (USD MILLION)
  • TABLE 77: OTHERS IN ROW: EUBIOTICS MARKET SIZE, BY TYPE, 2014-2022 (USD MILLION)
  • TABLE 78: OTHERS IN ROW: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2014-2022 (USD MILLION)
  • TABLE 79: EXPANSIONS & INVESTMENTS, 2010-2016
  • TABLE 80: MERGERS & ACQUISITIONS, 2010-2016
  • TABLE 81: NEW PRODUCT LAUNCHES, 2010-2016
  • TABLE 82: AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, AND JOINT VENTURES, 2010-2016
  • TABLE 83: EXPANSIONS & INVESTMENTS, 2010-2016
  • TABLE 84: MERGERS & ACQUISITIONS, 2010-2016
  • TABLE 85: NEW PRODUCT LAUNCHES, 2010-2016
  • TABLE 86: AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, AND JOINT VENTURES, 2010-2016

LIST OF FIGURES

  • FIGURE 1: EUBIOTICS MARKET SEGMENTATION
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 4: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 5: DATA TRIANGULATION
  • FIGURE 6: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2016 VS. 2022
  • FIGURE 7: PROBIOTICS PROJECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUBIOTICS MARKET FROM 2016 TO 2022
  • FIGURE 8: DRY FORM PROJECTED TO DOMINATE THE EUBIOTICS MARKET, 2016-2022
  • FIGURE 9: EUROPEAN REGION ACCOUNTED FOR LARGEST MARKET SHARE FOR EUBIOTICS IN 2015
  • FIGURE 10: EUBIOTICS: AN EMERGING MARKET WITH PROMISING GROWTH POTENTIAL, 2016-2022
  • FIGURE 11: GERMANY WAS THE FASTEST-GROWING MARKET FOR EUBIOTICS, 2015
  • FIGURE 12: EUROPEAN EUBIOTICS MARKET IS EXPERIENCING HIGH GROWTH
  • FIGURE 13: PROBIOTICS EXPECTED TO DOMINATE THE MARKET THROUGHOUT THE FORECAST PERIOD
  • FIGURE 14: INDIA & BRAZIL ARE PROJECTED TO BE THE MOST ATTRACTIVE MARKETS FOR EUBIOTICS DURING THE FORECAST PERIOD
  • FIGURE 15: EUROPE ACCOUNTED FOR THE LARGEST SHARE IN THE FORM SEGMENT IN 2015
  • FIGURE 16: POPULATION GROWTH TREND, 1961-2050
  • FIGURE 17: EUBIOTICS MARKET, BY TYPE
  • FIGURE 18: EUBIOTICS MARKET, BY FUNCTION
  • FIGURE 19: EUBIOTICS MARKET, BY FORM
  • FIGURE 20: EUBIOTICS MARKET, BY LIVESTOCK
  • FIGURE 21: MARKET DYNAMICS SNAPSHOT
  • FIGURE 22: NUMBER OF GMP+ FSA CERTIFIED* COMPANIES, 2009-2015
  • FIGURE 23: FOOD CHAIN APPROACH
  • FIGURE 24: FEED ADDITIVES GROWTH OUTLOOK ESTIMATED THROUGH 2022
  • FIGURE 25: CHANGE IN CONSUMER MEAT PREFERENCES, 2009 VS. 2014
  • FIGURE 26: ANNUAL SPENDING PER PET IN THE U.S., 2011-1016
  • FIGURE 27: MANUFACTURING CONTRIBUTES MAJOR VALUE TO OVERALL PRICE OF EUBIOTICS MARKET
  • FIGURE 28: RESEARCH ORGANIZATIONS & TECHNOLOGISTS: INTEGRAL PART OF SUPPLY CHAIN OF THE EUBIOTICS MARKET
  • FIGURE 29: PORTER'S FIVE FORCES ANALYSIS: EUBIOTICS MARKET
  • FIGURE 30: NUMBER OF PATENTS APPROVED FOR PROBIOTICS & PREBIOTICS IN ANIMAL FEED, 2012-2016
  • FIGURE 31: GEOGRAPHICAL ANALYSIS: PREBIOTICS AND PROBIOTICS PATENT APPROVAL, 2012-2016
  • FIGURE 32: PREBIOTICS SEGMENT TO BE THE FASTEST-GROWING IN THE EUBIOTICS MARKET
  • FIGURE 33: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2016-2022
  • FIGURE 34: DRY SEGMENT TO DOMINATE THE EUBIOTICS MARKET FROM 2016 TO 2022
  • FIGURE 35: CLASSIFICATION OF ANIMAL FEED ADDITIVES
  • FIGURE 36: EFFECT OF PROBIOTICS ON ANIMAL HEALTH
  • FIGURE 37: EUROPE: EUBIOTICS MARKET SNAPSHOT
  • FIGURE 38: CHINA WAS THE MARKET LEADER IN THE ASIA-PACIFIC REGION IN 2015
  • FIGURE 39: EXPANSIONS & INVESTMENTS: LEADING APPROACH OF KEY PLAYERS (2010-2016)
  • FIGURE 40: GLOBAL EUBIOTICS COMPANY RANKINGS (2015)
  • FIGURE 41: BATTLE FOR MARKET SHARE: EXPANSIONS AND INVESTMENTS WAS THE MOST POPULAR GROWTH STRATEGY
  • FIGURE 42: EXPANSIONS & INVESTMENTS FUELED GROWTH AND INNOVATION (2014-2016)
  • FIGURE 43: CARGILL: COMPANY SNAPSHOT
  • FIGURE 44: CARGILL: SWOT ANALYSIS
  • FIGURE 45: BASF SE: COMPANY SNAPSHOT
  • FIGURE 46: BASF SE: SWOT ANALYSIS
  • FIGURE 47: E.I. DUPONT DE NEMOURS AND COMPANY: COMPANY SNAPSHOT
  • FIGURE 48: E. I. DU PONT DE NEMOURS AND COMPANY: SWOT ANALYSIS
  • FIGURE 49: KONINKLIJKE DSM N.V. : COMPANY SNAPSHOT
  • FIGURE 50: KONINKLIJKE DSM N. V.: SWOT ANALYSIS
  • FIGURE 51: CHR. HANSEN A/S: COMPANY SNAPSHOT
  • FIGURE 52: CHR. HANSEN A/S: SWOT ANALYSIS
  • FIGURE 53: NOVOZYMES: COMPANY SNAPSHOT
Back to Top